ASSESSMENT OF ANTI-INFLAMMATORY ACTION OF VITEXIN USING IN VITRO MODELS
Abstract
In the present work the in vitro anti-inflammatory potential of vitexin was evaluated using two different models of inflammation, viz., inhibition of protein denaturation and inhibition of protease action. Both these models are based on the chemical mediators of inflammation and evaluating the drug on these models is self-evident of its anti-inflammatory property. Vitexin is a natural flavanol glycoside with iron chelating and antioxidant properties. It has diverse actions at the cellular and physiological levels, demonstrating anti-inflammatory, anti-cancer, and anti-fibrosis effects in animal models. The presence of peaks at 1727, 3407, 1462 and 2842 are indicative of the presence of carbonyl, hydroxyl, aromatic ring and aliphatic carbon respectively. The results of solubility analysis indicate that vitexin is soluble in organic solvents easily and is partially or sparingly soluble in aqueous solutions. The capacity of different concentrations of vitexin to inhibit protein denaturation of albumin was ranging from 20.33 ± 0.129 % to 69.63 ± 0.213 % in the assay and hence provides yet another evidence for its excellent anti-inflammatory property. The capacity of different concentrations of vitexin to inhibit serine protease was found to be ranging from 18.12 ± 0.214% to 75.21 ± 0.315% in the assay and therefore reinforces its tremendous anti-inflammatory property.
References
2. Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016 Dec;5:e47. doi:10.1017/jns.2016.41.
3. Xiao J, Chen X. Vitexin and isovitexin: chemical and pharmacological properties. Phytochem Rev. 2021 Mar;20(1):1-15. doi:10.1007/s11101-020-09695-3.
4. Zaki A, Mohsin M, Khan S, Khan A, Ahmad S, Verma A, Ali S, Fatma T, Syed MA. Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates SNHG1/DNMT1/miR-495 axis in sepsis-associated acute lung injury. Inflammopharmacology. 2024 Dec;32(6):2157-72. doi:10.1007/s10787-024-01609-6.
5. Senthamilan S, Aggarwal A, Grewal S, Rani S, Vats P, Pal P, Jaswal S, Arya A, Alhussien MN. Pre-treatment but not co-treatment with vitexin alleviates hyperthermia induced oxidative stress and inflammation in buffalo mammary epithelial cells. Journal of Reproductive Immunology. 2023 Aug 1;158:103979.
6. Kundu A, Ghosh P, Bishayi B. Vitexin along with verapamil downregulates efflux pump P-glycoprotein in macrophages and potentiates M1 to M2 switching via TLR4-NF-κB-TNFR2 pathway in lipopolysaccharide treated mice. Immunobiology. 2024 Jan;229(1):152767. doi:10.1016/j.imbio.2023.152767.
7. Osman NI, Sidik NJ, Awal A, Adam NAM, Rezali NI. In vitro xanthine oxidase and albumin denaturation inhibition assay of Barringtonia racemosa L. and total phenolic content analysis for potential anti-inflammatory use in gouty arthritis. J Intercult Ethnopharmacol. 2016;5(4):343-9. doi:10.5455/jice.20160922064205.
8. Kumari S, Yasmin N, Hussain MR, Babuselvam M. In vitro anti-inflammatory and anti-arthritic property of Rhizophora mucronata leaves. Int J Pharm Sci Res. 2015;6(2):482-5.
9. Oyedepo OO, Femurewa AJ. Anti-protease and membrane stabilizing activities of extracts of Fagra zanthoxiloides, Olax subscorpioides and Tetrapleura tetraptera. Int J Pharmacogn. 1995;33(1):65-9. doi:10.3109/13880209509088191.
10. Sakat S, Juvekar AR, Gambhire MN. In vitro antioxidant and anti-inflammatory activity of methanol extract of Oxalis corniculata Linn. Int J Pharm Pharm Sci. 2010;2(1):146-55.
11. PubChem. Vitexin ATR-IR spectra. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Vitexin#section=ATR-IR-Spectra [Accessed 31 Aug 2026].
12. Clearsynth. Vitexin CST62759. Available from: https://www.clearsynth.com/en/CST62759.html [Accessed 31 Aug 2026].
13. Raghu MG, Agrawal P. The isolation and structural determination of flavonoids from Justicia gendarussa. IOSR J Pharm Biol Sci. 2016;11(2):73-9. doi:10.9790/3008-11227379.
14. Opie EL. On the relation of necrosis and inflammation to denaturation of proteins. J Exp Med. 1962;115(3):597-608. doi:10.1084/jem.115.3.597.
15. Saso L, Valentini G, Casini ML, Grippa E, Gatto MT, Leone MG. Inhibition of heat-induced denaturation of albumin by nonsteroidal anti-inflammatory drugs (NSAIDs): pharmacological implications. Arch Pharm Res. 2001;24(2):150-8. doi:10.1007/BF02975129.
16. Das S, Chatterjee S. Long-term toxicity study of ART-400. Indian Indg Med. 1995;16(2):117-23.
17. Dai H, Korthuis RJ. Mast cell proteases and inflammation. Drug Discov Today: Dis Models. 2011;8(2-3):47-55. doi:10.1016/j.ddmod.2011.06.004.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







.